Efficient and cost-effective breast cancer risk stratification using whole slide histopathology images
Efficient and cost-effective breast cancer risk stratification using whole slide histopathology images
批准号:
10649978
负责人:
Metin Nafi Gurcan
金额:
$19.09万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-04-06 至 2025-03-31
关键词:
AgeAttentionBiological AssayBiological MarkersBiopsyBreast Cancer PatientBreast Cancer Risk FactorBreast Cancer therapyCancer PrognosisCategoriesCell NucleusCellsClassificationClinicalClinical ResearchClinical TrialsConsumptionDataDeveloping CountriesDiagnosisDiagnosticDiseaseDuct (organ) structureERBB2 geneEffectivenessEnsureEpitheliumEstrogen ReceptorsEstrogen receptor positiveEstrogensGene ExpressionGenesHealthHematoxylin and Eosin Staining MethodHistologicHistologyHistopathologyHumanImageImage AnalysisInternetInterobserver VariabilityLearningMalignant NeoplasmsMeasuresMethodsMissionModelingNatureOutcomePatientsPerformancePlayPopulationPremature MenopauseProgesteroneProgesterone ReceptorsPrognosisPublic HealthRecurrenceRecurrence ScoreRegional AnatomyResearchResource-limited settingResourcesReverse Transcriptase Polymerase Chain ReactionRiskSlideStainsStratificationTimeTissuesTrainingTumor TissueTumor stageUnited StatesUnited States National Institutes of HealthValidationWomanbreast imagingchemotherapycohortcostcost effectivedesigndetection methoddiagnostic accuracyerbB-2 Receptorhigh riskhormone receptor-positiveimaging biomarkerimprovedlarge datasetsmalignant breast neoplasmmortalitynovel strategiesoncotypeoptimal treatmentsoverexpressionpatient stratificationpersonalized carepreventprogesterone receptor positivereceptorrisk stratificationrural areaside effecttooltumorweb-based toolwhole slide imaging
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Efficient and cost-effective breast cancer risk stratification using whole-slide histopathology
images
Breast cancer prognosis depends highly on receptor status, as optimal treatment depends on
the presence or absence of overexpression of estrogen, progesterone, or HER-2/neu receptors.
To prevent over-treating patients with chemotherapy, it is crucial to quantify the risk of
recurrence for estrogen receptor (ER) positive (ER+), HER2 negative (HER2-) breast cancer. A
common assessment method to meet this need is the Oncotype DX (ODX) Recurrence Score.
Unfortunately, ODX and similar gene assays are expensive, time-consuming, and tissue
destructive. As an alternative, we propose estimating the ODX recurrence score using routine,
ubiquitous, and inexpensive hematoxylin and eosin (H&E) staining of biopsies. There are other
efforts to predict ODX recurrence risk from H&E. These automated methods detect histological
primitives (e.g., nuclei) often in specific, also automatically detected, anatomical regions (e.g.,
ducts, tubules, lumen, epithelium, and stroma). Classification is performed into two or three risk
categories, often collapsing two categories into one. The performance of these models is
promising but still modest. One way to improve the performance of the models is to train on
larger datasets; however, annotating larger datasets is challenging. Here, we propose an
automated method to predict ODX recurrence risk without annotations. If successful, this
method would have a wide range of applications, including but not limited to the availability of an
inexpensive, web-based tool to predict ODX in developing countries or rural areas with internet
access where standard Oncotype Dx assay would be cost-prohibitive or take too long to obtain.
Furthermore, our method would find use in clinical research where valuable tumor tissue could
be saved by obtaining correlative research data based on standard H&E-stained slides.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Computer-assisted diagnosis of ear pathologies by combining digital otoscopy with complementary data using machine learning
-
批准号:10564534
-
项目类别:
-
资助金额:$65.88万
-
财政年份:2023
-
负责人:Metin Nafi Gurcan
-
依托单位:
Culturally Augmented Learning In Biomedical Informatics Research (CALIBIR) Program
-
批准号:10631379
-
项目类别:
-
资助金额:$13.5万
-
财政年份:2022
-
负责人:Metin Nafi Gurcan
-
依托单位:
Culturally Augmented Learning In Biomedical Informatics Research (CALIBIR) Program
-
批准号:10701848
-
项目类别:
-
资助金额:$13.47万
-
财政年份:2022
-
负责人:Metin Nafi Gurcan
-
依托单位:
Analytics & Machine-learning for Maternal-health Interventions (AMMI): A Cross-CTSA Collaboration
-
批准号:10670448
-
项目类别:
-
资助金额:$115.72万
-
财政年份:2022
-
负责人:Metin Nafi Gurcan
-
依托单位:
Auto-Scope Software-Automated Otoscopy to Diagnose Ear Pathology
-
批准号:9790958
-
项目类别:
-
资助金额:$19.91万
-
财政年份:2018
-
负责人:Metin Nafi Gurcan
-
依托单位:
Pathology Image Informatics Platform for visualization, analysis and management
-
批准号:9341177
-
项目类别:
-
资助金额:$57.98万
-
财政年份:2015
-
负责人:Metin Nafi Gurcan
-
依托单位:
Computer-assisted Grading and Risk Stratification of Follicular Lymphoma
-
批准号:8215904
-
项目类别:
-
资助金额:$30.73万
-
财政年份:2009
-
负责人:Metin Nafi Gurcan
-
依托单位:
Computer-based assessment of tumor microenvironment (TME) in Follicular Lymphoma
-
批准号:9611415
-
项目类别:
-
资助金额:$21.38万
-
财政年份:2009
-
负责人:Metin Nafi Gurcan
-
依托单位:
OAMiner: Integrative Knowledge Anchored Hypothesis Discovery
-
批准号:7828221
-
项目类别:
-
资助金额:$58.42万
-
财政年份:2009
-
负责人:Metin Nafi Gurcan
-
依托单位:
Computer-assisted Grading and Risk Stratification of Follicular Lymphoma
-
批准号:8024533
-
项目类别:
-
资助金额:$27.24万
-
财政年份:2009
-
负责人:Metin Nafi Gurcan
-
依托单位:
Computer-assisted Grading and Risk Stratification of Follicular Lymphoma
-
批准号:7812178
-
项目类别:
-
资助金额:$31.59万
-
财政年份:2009
-
负责人:Metin Nafi Gurcan
-
依托单位:
Computer-based assessment of tumor microenvironment (TME) in Follicular Lymphoma
-
批准号:8758963
-
项目类别:
-
资助金额:$32.54万
-
财政年份:2009
-
负责人:Metin Nafi Gurcan
-
依托单位:
Computer-based assessment of tumor microenvironment (TME) in Follicular Lymphoma
-
批准号:8894440
-
项目类别:
-
资助金额:$29.78万
-
财政年份:2009
-
负责人:Metin Nafi Gurcan
-
依托单位:
Computer-based assessment of tumor microenvironment (TME) in Follicular Lymphoma
-
批准号:9070324
-
项目类别:
-
资助金额:$23.43万
-
财政年份:2009
-
负责人:Metin Nafi Gurcan
-
依托单位:
Computer-based assessment of tumor microenvironment (TME) in Follicular Lymphoma
-
批准号:9277412
-
项目类别:
-
资助金额:$2.04万
-
财政年份:2009
-
负责人:Metin Nafi Gurcan
-
依托单位:
Computer-assisted Grading and Risk Stratification of Follicular Lymphoma
-
批准号:7730133
-
项目类别:
-
资助金额:$32.06万
-
财政年份:2009
-
负责人:Metin Nafi Gurcan
-
依托单位:
OAMiner: Integrative Knowledge Anchored Hypothesis Discovery
-
批准号:7715205
-
项目类别:
-
资助金额:$58.04万
-
财政年份:2009
-
负责人:Metin Nafi Gurcan
-
依托单位:
国内基金
海外基金
多模态超声VisTran-Attention网络评估早期子宫颈癌保留生育功能手术可行性
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:郑巧
-
依托单位:
Ultrasomics-Attention孪生网络早期精准评估肝内胆管癌免疫治疗的研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:陈立达
-
依托单位: